SmallerStandardBiggerPrintRSS FeedFollow TVM Capital on TwitterSearch

Life Sciences Portfolio

More Information

Investment Focus of the Life Science Venture Capital Practice

  • Opportunities to create value through in-licensing or acquisition of innovative products as a result of restructuring in large pharmaceutical companies or restarts at development stage biotechnology companies
  • Companies that focus on the cost efficient development of a promising drug candidate or a family of drug candidates, usually from pre-clinical stage to first proof-of-concept in man (Phase IIa)
  • A broad range of other venture capital opportunities in Europe and the U.S. that span the entire universe from early stage biotech platform technology companies to companies active in the medtech, (molecular) diagnostic and other fields of product innovation in the life science.

Investment Focus of the Healthcare Private Equity Practice

  • European healthcare SMEs with excellent growth prospects in need of expansion capital and a supportive industry network to finance & actively contribute to their business expansion and/or reorganizing of their shareholder base.
  • Corporate disposals of marketed products, or product portfolios or entire business units that are no longer part of the core strategy of the parent company and that can constitute stand-alone companies with excellent growth prospects if given the right support and environment
  • Buyouts of shareholder positions in attractive European SME’s in Pharma, Medtech and Healthcare Services, very often in combination with a growth capital financing supporting the positive business fundamentals already existing in these companies